Le Lézard
Classified in: Health
Subjects: NPT, VET, DIS

CVS Health and its Foundation Commemorate Veterans Day With $580,000 in Grants to Easterseals To Assure Access to Healthcare and Smoking Cessation Support for Veterans and Military Families


CHICAGO, Nov. 9, 2017 /PRNewswire-USNewswire/ -- This Veteran's Day, Easterseals announced it has received $580,000 in grants from CVS Health and the CVS Health Foundation to support local services that ensure access to healthcare and smoking cessation resources for Veterans and military families. 

Easterseals logo

As part of the funding, Easterseals has received $70,000 for national programming and six Easterseal affiliates who excel in programs that respond to the local needs of Veterans, their family members and caregivers will each receive a $10,000 grant. Beneficiaries include:

"CVS Health and Easterseals share a commitment to the health and well being of all Americans," said Eileen Howard Boone, senior vice president of Corporate Social Responsibility for CVS Health and president of the CVS Health Foundation.  "As Veterans Day approaches, we're proud to honor our nation's Veterans with support to a partner like Easterseals which offers community-based services for  Veterans and their families."

In addition to the grants that will expand access to care, CVS Health Foundation has also donated $450,000 in grants to help advance Easterseals' commitment to helping Americans live tobacco-free lives, including those populations served by Easterseals which have a higher incidence of smoking among Veterans and their caregivers. Several local affiliates have received funding to achieve the following outcomes:

About Easterseals
Easterseals is the leading non-profit provider of services for people living with disabilities, including Veterans and their caregivers.  Through therapy, training, education and support services, Easterseals creates life-changing solutions so that people with disabilities, can live, learn, work and play in their communities.  For more information, visit www.easterseals.com

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com/.

 

SOURCE Easterseals


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: